Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medicus Pharma Ltd. - Common Stock
(NQ:
MDCX
)
0.4066
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
46,223
Open
0.4066
Bid (Size)
0.3985 (2,000)
Ask (Size)
0.4074 (2,400)
Prev. Close
0.4066
Today's Range
0.4066 - 0.4066
52wk Range
0.3700 - 8.940
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
March 30, 2026
Dr. Babar Rao highlights clinically meaningful outcomes with majority of lesions potentially avoiding immediate surgery in non-melanoma Skin Cancer
From
Medicus Pharma Ltd
Via
GlobeNewswire
Medicus Pharma (MDCX): A Small-Cap Biotech Making Moves in 2026
March 27, 2026
Via
AB Newswire
Performance
YTD
-74.6%
-74.6%
1 Month
-72.9%
-72.9%
3 Month
-72.2%
-72.2%
6 Month
-83.8%
-83.8%
1 Year
-89.1%
-89.1%
More News
Read More
Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
March 26, 2026
From
Medicus Pharma Ltd
Via
GlobeNewswire
Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update
March 25, 2026
Via
ACCESS Newswire
Medicus Pharma on Bloomberg World
February 12, 2026
Via
ACCESS Newswire
Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst
March 18, 2026
Via
ACCESS Newswire
Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26
March 16, 2026
From
Medicus Pharma Ltd
Via
GlobeNewswire
New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST
March 14, 2026
Via
ACCESS Newswire
Unusual volume stocks in Tuesday's session
↗
March 10, 2026
Via
Chartmill
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
March 10, 2026
Via
ACCESS Newswire
These stocks are making the most noise in today's session.
↗
March 09, 2026
Via
Chartmill
American Lithium Minerals (OTC: AMLM) Targets Tokenized Commodities Opportunity Alongside MDCX, ASNS, EONR, ELPW Today!
March 09, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Monday's session: top gainers and losers
↗
March 09, 2026
Via
Chartmill
Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset
March 09, 2026
From
Medicus Pharma Ltd
Via
GlobeNewswire
New to The Street Broadcasts Tonight on Bloomberg Television at 6:30 PM EST - Shows 736, 737 and 738 Air Across the U.S., Latin America and MENA
March 07, 2026
Via
ACCESS Newswire
Here are the top movers in Friday's session.
↗
March 06, 2026
Via
Chartmill
Which stocks are moving on Friday?
↗
March 06, 2026
Via
Chartmill
The market is filled with gapping stocks in Friday's session.
↗
March 06, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Thursday's session.
↗
March 05, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Thursday?
↗
March 05, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
March 05, 2026
Via
Chartmill
Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort
March 05, 2026
From
Medicus Pharma Ltd
Via
GlobeNewswire
Medicus Pharma To Participate in the 38th Annual Roth Conference
March 03, 2026
From
Medicus Pharma Ltd
Via
GlobeNewswire
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM EST
February 28, 2026
Via
ACCESS Newswire
New to The Street Signs Six-Part Media Series Featuring Medicus Pharma Ltd.
February 10, 2026
Via
ACCESS Newswire
Frequently Asked Questions
Is Medicus Pharma Ltd. - Common Stock publicly traded?
Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
What exchange does Medicus Pharma Ltd. - Common Stock trade on?
Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
What is the current price of Medicus Pharma Ltd. - Common Stock?
The current price of Medicus Pharma Ltd. - Common Stock is 0.4066
When was Medicus Pharma Ltd. - Common Stock last traded?
The last trade of Medicus Pharma Ltd. - Common Stock was at 03/30/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.